Search

everythinglearnresearchcommunity

for

Search:↓

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 may cause temporary hair loss due to the body's immune response.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

The pandemic stress may have increased alopecia cases in Bangladesh.

COVID-19 may cause temporary hair loss in some people.

COVID-19 can cause a temporary hair loss condition.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

The May 2021 issue of the Journal of Cosmetic Dermatology suggests injectables are becoming more reliable and may reduce the need for cosmetic surgery.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Rosemary oil and minoxidil 2% both effectively increase hair count in people with androgenetic alopecia, but rosemary oil causes less scalp itching.

Intravenous delivery of autologous activated platelet-rich plasma is safe.

Facial plastic surgeries and aesthetic procedures are becoming more popular in India, with a preference for non-surgical options and effective treatments for facial enhancement and hair loss.

Hair intradermotherapy effectively treats hair loss and boosts self-esteem.

Hair transplant techniques have improved and become less invasive over time, but there are concerns about unregulated centers. The market is growing, with potential for more growth in India due to increasing hair loss cases. New technologies like robotic transplants are promising for the future. Surgeons are encouraged to prioritize patient safety and understand the science behind their techniques.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

A functional medicine approach may help long COVID patients by focusing on adrenal fatigue, gut health, and vitamin D deficiency, using diagnostic tools and lifestyle changes.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Some people lose a lot of hair after having COVID-19.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

COVID-19 vaccination may trigger lupus in some people.